Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus

Trial Profile

Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Canagliflozin (Primary) ; Dapagliflozin (Primary) ; Empagliflozin (Primary) ; Dipeptidyl peptidase 4 inhibitors; Glucagon-like peptide 1 agonist; Insulin; Sulfonylureas; Thiazolidinediones
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms EASEL
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 17 Nov 2017 Primary endpoint has been met. (Incidence Rate of the Composite of All-cause Mortality (ACM) or Hospitalization for Heart Failure (HF)), according to a Janssen Pharmaceuticals media release.
    • 17 Nov 2017 Results of retrospective analysis presented in a Janssen Pharmaceuticals media release.
    • 17 Nov 2017 Status changed from active, no longer recruiting to completed.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top